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Synthesis of N-((1H-benzo[d]imidazol-1-yl)methyl)-N-(2-(trifluoromethyl)phenyl)-4,5-dihydrothiazol-2-amine was done 
followed by its characterization by various spectral techniques. DFT studies of the compound were performed at B3LYP 
level to study various structural parameters and thermodynamic variables. The correlation of observed transitions with the 
electronic transitions had been done via NBO analysis. In addition to it, the HOMO and LUMO energy gaps and 
identification of sites liable for electrophilic and nucleophilic attack were done by MESP and ESP plots. 
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1 Introduction 
Heterocyclic moieties possessing nitrogen and 
sulphur nucleus display a myriad of biological activities 
and possess an important place in the pharmaceutical 
industry1-3. Thiazole, a well known heterocyclic 
compound, has significant role in the development 
of newer drugs4-6. Among the wide range of 
pharmacological activities displayed by thiazole, some 
worth mentioning include antimicrobial, anti allergic, 
anti hypertensive, anti inflammatory, anti HIV, 
antioxidant, and antianalgesic 7-28. 
Imidazole nucleus, another therapeutically 
important moiety, has broad applications as 
anticancer, antifungal, antiviral, anti tubercular, and 
antimalarial29-42 agent. Thus it was thought worth 
while to synthesize a new hybrid molecule 
incorporating both thiazole and imidazole moieties 
with a good activity profile. In this paper, the 
synthesis of N-((1H-benzo[d]imidazol-1-yl)methyl)-
N-(2-(trifluoromethyl)phenyl)-4,5-dihydrothiazol-2-
amine (3)along with its characterization by spectral 
analysis and computational method is described. 
Experimental and theoretical spectral results for 
compound 3 have also been compared. 
2 Materials and Method 
The spectrophotometers used for spectral analysis 
of molecule are-Bruker 400 MHz for NMR, 
Perkin-Elmer Fourier transform for IR and Double-
Beam spectrophotometer for UV spectroscopy. The 
solvent used was CDCl3 while tetra methylsilane 
served the purpose of internal reference. 
2.1. Procedure for synthesis of N-((1H-benzo[d]imidazol-1-
yl)methyl)-N-(2-(trifluoromethyl)phenyl)-4,5-dihydrothiazol-
2-amine(3)
0.014 mole of conc. HCl was added slowly to the
solution (ice cold) of 0.01 mole of an amine 2 in 
20 ml alcohol. Para form aldehyde was added in small 
proportions to the reaction mixture while keeping it 
into the ice for half an hour. 0.01 mole of 1 was added 
to this and the reaction mixture was refluxed for 2 hrs 
on water bath. A reddish brown semisolid was 
obtained as a product after concentrating the reaction 
mixture (Scheme 1, Fig. 1). Yield-61%, melting 
point-20-25 0C, Rf: 0.62(20% CHCl3:CH3OH), IR 
(KBr, cm-1): 3018(=C-H stretching), 2850 and 2825 
(-CH stretching), 1467(-C=N stretching), 1298(-C-N 
stretching), 1149 and 1036(-C-F stretching), 773 




Scheme 1 — Synthesis of N-((1H-benzo[d]imidazol-1-yl)methyl)-
N-(2-(trifluoromethyl)phenyl)-4,5-dihydrothiazol-2-amine. 




3.81(t,2H) 5.27(s,2H), 7.21-6.96 (m,5H);7.57-6.55 
(t, 1H); 8.03-8.02(t, 1H); 7.74-7.72(m,2H) 
13CNMR:34.05,61.40,68.76,110.19,116.81,117.39, 
119.95,122.54,123.04,124.28,126.06,128.33,131.76,132.
69,141.66, 143.40, 144.00, 160.40; m/z- 377 ( M+1) 
 
3 Computational Details 
The computational studies of N-((1H-benzo [d] 
imidazol-1-yl)methyl)-N-(2-(trifluoromethyl) phenyl)- 
4,5-dihydrothiazol-2-amine were performed at 
(B3LYP)43-45 with 6-31G (d,p) as basis set with the 
Gaussian 09 package46. 
Gauss View 05 program was used to get the 
graphical presentations of calculated IR and UV 
spectra. The calculation of 1H NMR chemical shifts 
by GIAO method47and NBO calculations48along with 
Frontier orbital analysis were also done in CHCl3 by 
using IEFPCM model. AIM method was employed 
for studying interactions within the molecule49. 
 






C NMR spectra 
The experimental and calculated 1H and 13C NMR 
shift values have been enlisted in Table 1. The 
correlation graph which is as per the equation,
0.895 0.715y x  , for 
1H NMR and 1.021 4.219y x   
for 13C NMR (where ‘y’ represents experimental 
value and ‘x’ manifests calculated shift value in ppm) 
is shown in Figs. 2(a-b) respectively. The calculated 
value for protons in aromatic region lies in the range 
of δ 6.655 to δ8.5784 which matches well with the 
experimental proton shift at δ 6.96 to δ 8.03.  
The correlation values (R² = 0.912) for 1H NMR and 
(R² = 0.934) for 13C NMR depicted that the 
experimental and theoretical values are in good 
accordance with each other. The aromatic proton 
values in the spectrum at 7.05-7.03 and 8.03-6.96 
ppm corresponded to H27, H28, H29, H30, H31, H32, 
and H33 protons respectively. 
 
 
Fig. 1 — Optimized Structure of the title compound. 
 
Table 1 — Experimental and calculated 1HNMR and 13CNMR chemical shifts of the title compound using DFT/B3LYP 6-31G (d,p). 
Carbon atom Calculated 13CNMR 











chemical shift  
(ppm) 
1C 121.1 122.54 27H 7.123 7.05 
2C 119.878 123.04 28H 7.327 7.05 
3C 118.8905 124.28 29H 7.7714 7.03 
4C 141.1649 141.66 30H 6.6555 7.03 
5C 132.6355 132.69 31H 8.5784 8.03 
6C 107.323 119.95 32H 6.6769 6.96 
8C 139.7771 143.4 33H 5.4242 6.96 
10C 65.4117 68.76 34H 3.4387 3.71 
12C 140.9456 144 35H 3.5736 3.71 
13C 161.0253 160.4 36H 4.087 3.83 
15C 45.9626 34.05 37H 3.8117 3.83 
16C 65.3014 61.4 38H 6.7675 6.96 
18C 132.5252 110.19 39H 7.347 7.56 
19C 130.4564 131.76 40H 7.6085 7.57 
20C 126.5229 117.39 41H 7.9288 7.74 
21C 126.2921 128.33    
22C 129.3733 116.81    
23C 131.8513 126.06    
 




4.2 UV-Visible spectrum 
The effect of solvent has been considered  
by employing IEFPCM50, 51. The experimental and 
calculated data for electronic transitions has been 
depicted in Table 2 (Fig. 3). A HOMO-LUMO 
transition at 238 nm (ƒ = 0.0638) in chloroform was 
observed and complied well with experimental data  
(λ exp. = 270 nm), as shown in Fig. 4. 
 
4.3 Vibrational Assignments 
The vibrational analysis of compound showed the 
presence of 41 atoms which belong to C1 point group 
possessing 117 normal modes of vibrations. Table 3 
contains experimental and scaled52 calculated wave 
numbers. Correlation coefficient value (R2= 0.967) 
showed a strong correlation between experimental 
and calculated wave numbers. The correlation 
graphics has been sketched in Fig. 5 while the FT-IR 
spectrum (theoretical) is depicted in Fig. 6. The 
experimental value for vibrational bands of =CH 
stretching appeared at 3018 cm-1 agreed well with the 
 
 
Fig. 2 — Correlation graph between (a) experimental and 
calculated 1HNMR chemical shifts (b) experimental and 
calculated 13CNMR chemical shifts using B3LYP 6-31G (d, p). 
 
Table 2 — Experimental and theoretical absorption wavelengths λ (nm) and excitation energies E (eV) of title compound using B3LYP 
functional and 631-G/(d,p) basis set. 
S. No. Major contributing Molecular  
orbitals 




Assignment Observed  
(λmax) 









Fig. 4 — HOMO-LUMO molecular orbital of the title compound. 




calculated value at 3204 cm-1. The experimental and 
calculated vibrational bands for symmetric C-H 
stretching appeared at 2850, 2825 cm-1& at 1577, 
1548 cm-1 respectively. The experimental and 
calculated C-F stretching appeared at 1149, 1036cm-1 
& at 1132, 1140 cm-1 respectively. The C-S stretching 
band appeared at 773 & 780 cm-1 as observed 
experimentally and theoretically. 
 
4.4 Molecular electrostatic potential 
The MESP (shown in Fig. 7) and ESP maps 
(shown in Fig. 8) indicated the electron rich and 
electron deficient centres53-55. The tendency to accept 
electrons for a specific site follows the order as  
red < yellow< green < light blue < blue56-60. As per 
the MESP map, it is observed that the most preferred 
region for electrophilic and nucleophilic attack are 
around C10, C15 & C16 (MESP value=-7.352 a.u.) 
and N7 (MESP value=+7.352 a.u.) respectively. 
Magnitude of positive charge on H34 atom and 
negative charge over oxygen atom affirms the 
presence of the C-H…O hydrogen bonding in the 
molecule 3.  
 
4.5 Natural bond orbital analysis 
Natural bond orbital (NBO) analysis61 has been 
used time and again to explore the charge transfer 
within the molecular systems. The NBO analysis has 
been in Table 4. 
Table 3 — Experimental FT-IR and calculated vibrational 
frequencies in cm-1 for title compound. 
Experimental Calculated B3LYP Vibrational assignment 
3018 3204 =CH stretching 
2850 2940 Symmetric C-H stretching 
2825 2452 Symmetric C=N stretching 
1467 1548 Symmetric C=N stretching 
1298 1340 Symmetric C-N stretching 
1149 1132 C-F stretching 
1036 1140 C-F stretching 


















Fig. 8 — Electrostatic potential contour surface of the title 
compound. 
 




The NBO analysis62 disclosed that significant 
delocalization can be affirmed within the system as 
evident from the charge transfer from π (C19-C20) to π* 
(C12-C18) and from N9 to ζ* (C4-C5) with stabilization 
energy values of 22.25 and 32.66 kcal mol-1. Apart from 
these transisitions other π→π * and n→π* intra 
molecular transistions are also seen with stabilisation 
energy values ranging between 5-20 kcal mol-1  
thus showing delocalisation of electrons within  
the system. 
 
4.6 Non -linear optical analysis 
NLO analysis, has always allured the interest of 
researchers due to its application63,64 in signal 
processing, modulation, optical logic and other such 
fields. The presence of conjugation in organic systems 
can be attributed to polarization leading to a high 
value of NLO coefficient.  
The corresponding NLO analysis is presented  
in Table 5. The calculated dipole moment65, 
polarizability αtot and first hyper polarizability for the 
Table 4 — Second order perturbation theory analysis of Fock matrix in NBO basis of the title compound. 
Donar Type ED/e Acceptor Type ED/e* (E2)a (Ej-Ei)b (Fij)c 
BD(1)C1-C6 n 1.972 BD*(1)C5-N9 ζ* 0.033 7.06 1.14 0.08 
BD(2)C1-C6 ζ 1.728 BD*(2)C2-C3 ζ* 0.307 17.22 0.29 0.064 
BD(2)C1-C6 ζ 1.728 BD*(2)C4-C5 ζ* 0.474 19.53 0.28 0.07 
BD(1)C2-C3 n 1.978 BD*(1)C4-N7 ζ* 0.02 5.25 1.06 0.035 
BD(2)C2-C3 ζ 1.715 BD*(2)C1-C6 ζ* 0.0334 20.24 0.28 0.068 
BD(2)C2-C3 ζ 1.715 BD*(2)C4-C5 ζ* 0.474 18.34 0.27 0.066 
BD(1)C4-C5 ζ 1.967 BD*(1)N9-C10 ζ* 0.054 5.6 1 0.067 
BD(2)C4-C5 ζ 1.596 BD*(2)C1-C6 ζ* 0.334 18.85 0.28 0.066 
BD(2)C4-C5 ζ 1.596 BD*(2)N7-C8 ζ* 0.307 14.5 0.29 0.067 
BD(2)C4-C5 ζ 1.596 BD*(2)N7-C8 ζ* 0.306 14.5 0.26 0.056 
BD(1)C4-N7 n 1.976 BD*(1)C8-H31 ζ* 0.022 5.59 1.23 0.074 
BD(1)N7-C8 n 1.985 BD*(1)C3-C4 π* 0.023 5.71 1.42 0.081 
BD(1)C8-C9 n 1.985 BD*(1)C5-C6 π* 0.021 5.02 1.37 0.074 
BD(2)C12-C18 π 1.656 BD*(2)C19-C20 π* 0.311 19.47 0.29 0.067 
BD(2)C12-C18 π 1.656 BD*(2)C21-C22 π* 0.357 20.72 0.28 0.069 
BD(2)C19-C20 π 1.646 BD*(2)C12-C18 π* 0.326 20.7 0.28 0.068 
BD(2)C19-C20 π 1.646 BD*(2)C12-C18 π* 0.326 22.25 0.28 0.07 
BD(2)C21-C22 π 1.67 BD*(2)C12-C18 π* 0.326 20.73 0.29 0.069 
BD(2)C21-C22 π 1.67 BD*(2)C19-C20 π* 0.311 18.26 0.29 0.065 
LP(1)N9 n 1.602 BD*(2)C4-C5 ζ* 0.474 32.66 0.3 0.089 
LP(1)N11 n 1.746 BD*(1)C12-C18 π* 0.026 6.56 0.83 0.07 
LP(1)N11 n 1.746 BD*(1)C12-C22 ζ* 0.034 5.85 0.81 0.065 
LP(1)N17 n 1.86 BD*(1)C15-C16 ζ* 0.03 5.28 0.69 0.55 
aE(2) means energy of hyperconjugative interactions (stabilization energy in Kcal/mol) 
b Energy difference between donor and acceptor i and j NBO orbitals in a.u. 
c F(ij) is the Fock matrix elements between i and j NBO orbitals in a.u. 
 
Table 5 — Dipole Moment μ, Polarizability αtot (ˣ10
-24esu) and first order static hyperpolarizability βtot (10
-30)  
data of the title compound. 
Dipole moment B3LYP 6-31G (d,p) Hyperpolarizability B3LYP6-31G (d,p) 
µx 1.511 βxxx 0.395501 
µy -1.4388 βxxy 0.798569 
μz 1.3088 βxyy 0.75098 
µ 2.463 βyyy -0.04315 
Polarizability    
αxx 36.60095 βxxz -0.06566 
αxy 3.690254 βxyz 0.129544 
αyy 37.46941 βyyz 0.419359 
αxz -2.60948 βxzz -0.25118 
αyz -0.90724 βyzz 0.159932 
αzz 24.03611 βzzz 0.040234 
(α) 32.70216 βtotal (esu) 1.3396 
 




title compound are 2.463 D, 32.70216×10−24 esu  
and 1.3396×10-30 esu respectively for B3LYP level. 
 
4.7 Thermodynamical analysis 
Thermodynamic data (heat capacity and entropy) 
tabulated in the supplementary Table 6(a-b) for the 
title compound 3, while the correlation graphics is 
shown in Fig. 9. The results indicated that the values 
of thermodynamic parameters increase with rise in 
temperature which is attributed to the progression in 
vibrational intensities with temperature. 
 
4.8 Reactivity descriptors 
 
4.8.1 Global Reactivity Descriptors 
Global reactivity descriptors are used to establish 
the structure-stability relationship. These descriptors 
are listed in Table 7. In this regard, Koopman’s 
theorem can be very well employed for ascertaining 
reactivity in chemical environment and selectivity of a 
particular electronic site66-70. The value of chemical 
potential is a clear indicator of stability of 3. 
 
 
4.8.2. Local reactivity descriptors 
Local reactivity descriptors71,72 are used for the 
analysis of reactivity orientation of specific sites 
within the molecule (Table 8). The relatively enhanced 
values of reactivity descriptors observed at C10,C15 
and C16 are indicator of sites of nucleophilic activity 
while the increased values of these descriptors at N7 
suggest it to be a site of electrophilic activity. 
 
4.9 AIM approach 
Molecular graph of 3 is sketched in Fig. 10.  
The intense, average and weak H-bonds can be 
Table 6(a) — Calculated thermodynamic parameters of  
title compound. 
Parameters B3LYP/6-31 G(d,p) 
Zero-point vibrational energy 
(Kcal/mol) 
193.7399 
Rotational temperatures (K)  0.01196 
 0.00814 
 0.00600 









Table 6(b) — Thermodynamic functions at different temperatures 




(Cal/mol K) B3LYP 
Entropy(S)(Cal/Mol K) 
B3LYP 
100 33.589 100.32 
200 57.158 132.077 
298.15 83.08 160.50 
300 83.568 161.028 
400 108.479 189.131 
500 129.366 216.106 
 
Table 7 — Calculated εLUMO, εHOMO, energy band gap εHOMO– εLUMO, ionization potential (IP), electron affinity (EA), electronegativity (χ), 
global hardness (η), chemical potential (μ), global electrophilicityindex (ω), global softness (S) and additional electronic charge (∆Nmax) 
in eV for the title compound, using DFT/B3LYP/6-31G(d,p). 
ϵH ϵL ϵH-ϵL I A Χ ɳ μ 𝜔 S ∆N Max 




Fig. 9 — Correlation graphs of heat capacity and entropy 




Fig. 10 — Molecular graph of the title compound using  
AIM program at B3LYP/6- 31G (d,p) level ring critical points 
(small blue sphere), bond paths (red lines). 
 




denoted by 2ρ(BCP) < 0 and HBCP < 0, 2ρ (BCP) 
> 0 and HBCP < 0 and 2ρ(BCP) > 0 and HBCP > 0 
respectively73. 
Geometrical and topological parameters along  
with ellipticity (ε) values, are given in Table 9. 
According to AIM computations, the overall energy 
of interactions within the molecule comes out to be -
0.0903 kcal/mol. Along with this, delocalization  
was further confirmed by the decreased ellipticity 
data. 
5 Conclusion 
The present work comprises of synthesis and 
respective characterization NovelN-((1H-benzo[d] 
imidazol-1-yl)methyl)-N-(2-(trifluoromethyl) 
phenyl)-4,5-dihydrothiazol-2amine(3) by spectral and 
computational methods. The experimental and 
theoretical results were found in good compliance 
with each other. The biological activity of the 
molecule could be anticipated by HOMO-LUMO 
values. As per the results obtained from NLO 
Table 8 — Fukui functions (fk+,fk-), Local softness (sk+sk-) in eV, Local electrophilicity indices (wk+,wk-) in eV for specific atomic sites 
of the title compound. 




1 C 0.005583 0.059766 -0.04753 0.054183 0.053108 0.013649 0.013378 0.157889 0.154757 
2 C -0.02422 0.055447 -0.11048 0.079669 0.08626 0.020069 0.021729 0.232155 0.251362 
3 C 0.066555 0.051623 0.023143 -0.01493 0.043412 -0.00376 0.010935 -0.04351 0.126503 
4 C 0.181424 0.327256 0.162139 0.145832 0.019285 0.036735 0.004858 0.424954 0.056196 
5 C 0.062145 0.093621 0.066016 0.031476 -0.00387 0.007929 -0.00098 0.091721 -0.01128 
6 C -0.02914 -0.05066 -0.08578 -0.02152 0.056638 -0.00542 0.014267 -0.0627 0.165043 
7 N -0.57965 -0.68738 -0.58829 -0.10773 0.008643 -0.02714 0.002177 -0.31392 0.025186 
8 C 0.437848 0.611499 0.373951 0.173651 0.063897 0.043743 0.016096 0.506019 0.186196 
9 C 0.040277 -0.05155 0.033344 -0.09183 0.006933 -0.02313 0.001746 -0.26759 0.020203 
10 C 0.227316 0.326354 0.167412 0.099038 0.059904 0.024948 0.01509 0.288597 0.17456 
11 C 0.184922 0.18098 0.186966 -0.00394 -0.00204 -0.00099 -0.00051 -0.01149 -0.00596 
12 C 0.100987 0.043082 0.108188 -0.05791 -0.0072 -0.01459 -0.00181 -0.16874 -0.02098 
13 C -0.03672 0.022189 -0.08586 0.058908 0.049138 0.014839 0.012378 0.171658 0.143188 
14 C -0.00126 0.04985 -0.05098 0.051105 0.04972 0.012873 0.012524 0.14892 0.144884 
15 C -0.01577 0.021029 -0.05944 0.036801 0.043669 0.00927 0.011 0.107238 0.127251 
16 C -0.0089 0.043396 -0.01913 0.052299 0.010229 0.013174 0.002577 0.152399 0.029807 
17 O -0.10937 -0.46971 -0.14579 -0.36035 0.036423 -0.09077 0.009175 -1.05005 0.106137 
18 O -0.23856 -0.20467 -0.29299 0.033888 0.054433 0.008536 0.013712 0.09875 0.158618 
19 C 0.103464 0.166891 0.082497 0.063427 0.020967 0.015977 0.005282 0.184826 0.061098 
20 C 0.078419 0.096224 0.070549 0.017805 0.00787 0.004485 0.001982 0.051884 0.022933 
21 N -0.42095 -0.33046 -0.42001 0.090499 -0.00094 0.022797 -0.00024 0.263714 -0.00275 
22 C -0.1239 -0.14966 -0.12968 -0.02576 0.005783 -0.00649 0.001457 -0.07506 0.016852 
23 C 0.004138 0.071025 -0.05311 0.066887 0.057247 0.016849 0.014421 0.194909 0.166818 
24 C 0.002448 0.05635 -0.05469 0.053902 0.057134 0.013578 0.014392 0.15707 0.166488 
25 C -0.01469 0.032205 -0.06627 0.046894 0.051583 0.011813 0.012994 0.136649 0.150313 
26 C -0.18143 0.05325 -0.21222 0.234677 0.030792 0.059115 0.007757 0.683849 0.089728 
27 C 0.152208 0.21862 0.163994 0.066412 -0.01179 0.016729 -0.00297 0.193525 -0.03434 
28 C -0.00241 0.054398 -0.02665 0.056805 0.024247 0.014309 0.006108 0.16553 0.070656 
29 C -0.01009 0.044521 -0.0401 0.054612 0.03001 0.013757 0.00756 0.159139 0.087449 
30 C 0.003856 0.05844 -0.02402 0.054584 0.027876 0.01375 0.007022 0.159058 0.081231 
31 C 0.173736 0.214022 0.17231 0.040286 0.001426 0.010148 0.000359 0.117393 0.004155 
32 Cl -0.02828 -0.00796 -0.0975 0.020314 0.06922 0.005117 0.017437 0.059195 0.201707 
 
Table 9 — Topological parameters for intramolecular interactions in compound electron density (ρBCP), Laplacian of electron density 
(∇2ρBCP), electron kinetic energy density (GBCP), electron potential energy density (VBCP), total electron energy density (HBCP), Hydrogen 
bond energy (EHB) at bond critical point (BCP). 
Interactions ρBCP ∇
2ρBCP GBCP VBCP HBCP EHB(Elipticity) 
C8-H31···S14 0.005956 0.017975 0.003451 -0.002409 0.000087 0.017150 
C10-H32···S14 0.013745 0.055005 0.011449 -0.009147 -0.000872 0.921598 
C10-H33···F24 0.010307 -0.334598 0.009827 -0.008290 -0.00125 0.260783 
ρBCP, ∇
2ρBCP, GBCP, VBCP, HBCP in a.u. and EHB in (kcal/mol) 
 




analysis, the molecule turns out to be a potent  
NLO material. Ellipticity and hydrogen bonding 
interatctions, as investigated by the AIM, depicted π-
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